BG99680A - Derivatives of oxalylaminobenzofuran and oxalylaminobenzothienyl - Google Patents

Derivatives of oxalylaminobenzofuran and oxalylaminobenzothienyl

Info

Publication number: BG99680A
Authority: BG; Bulgaria
Prior art keywords: derivatives; oxalylaminobenzothienyl; oxalylaminobenzofuran; prophylaxy; aminosubstituted
Prior art date: 1994-05-31

Application number

BG99680A

Other languages

English (en)

Inventor

Gabriele Braeunlich

Ruediger Fischer

Mazen Es-Sayed

Rudolf Hanko

Stephen Tudhope

Graham Sturton

Trevor Abram

Wendy J Donald-Gibson

Mary F Fitzgerald

Original Assignee

Braeunlich

Fischer

Es Sayed

Hanko

Tudhope

Sturton

Abram

Donald Gibson

Fitzgerald

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-31

Filing date

1995-05-30

Publication date

1996-01-31

1994-05-31 Priority claimed from GB9410863A external-priority patent/GB9410863D0/en

1994-05-31 Priority claimed from GB9410891A external-priority patent/GB9410891D0/en

1995-05-30 Application filed by Braeunlich, Fischer, Es Sayed, Hanko, Tudhope, Sturton, Abram, Donald Gibson, Fitzgerald filed Critical Braeunlich

1996-01-31 Publication of BG99680A publication Critical patent/BG99680A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Furan Compounds (AREA)
Display Devices Of Pinball Game Machines (AREA)
Indole Compounds (AREA)
Manufacturing Optical Record Carriers (AREA)
Materials For Photolithography (AREA)
Medicinal Preparation (AREA)

BG99680A 1994-05-31 1995-05-30 Derivatives of oxalylaminobenzofuran and oxalylaminobenzothienyl BG99680A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9410863A GB9410863D0 (en)	1994-05-31	1994-05-31	Heterocyclycarbonyl substituted oxalylamino-benzofurane derivatives
GB9410891A GB9410891D0 (en)	1994-05-31	1994-05-31	Oxalylamino-benzofuran-and benzothienyl-derivatives

Publications (1)

Publication Number	Publication Date
BG99680A true BG99680A (en)	1996-01-31

Family

ID=26304969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG99680A BG99680A (en)	1994-05-31	1995-05-30	Derivatives of oxalylaminobenzofuran and oxalylaminobenzothienyl

Country Status (29)

Country	Link
US (1)	US5565488A (ja)
EP (1)	EP0685474B1 (ja)
JP (1)	JPH083154A (ja)
KR (1)	KR950032163A (ja)
CN (1)	CN1119187A (ja)
AT (1)	ATE171172T1 (ja)
AU (1)	AU695464B2 (ja)
BG (1)	BG99680A (ja)
CA (1)	CA2150301A1 (ja)
CO (1)	CO4600675A1 (ja)
CZ (1)	CZ140895A3 (ja)
DE (1)	DE69504753T2 (ja)
DK (1)	DK0685474T3 (ja)
EE (1)	EE9500034A (ja)
ES (1)	ES2124461T3 (ja)
FI (1)	FI952612L (ja)
HR (1)	HRP950288A2 (ja)
HU (1)	HUT71597A (ja)
IL (1)	IL113894A (ja)
LV (1)	LV11467B (ja)
MA (1)	MA23603A1 (ja)
MY (1)	MY130580A (ja)
NO (1)	NO952129L (ja)
NZ (1)	NZ272217A (ja)
PL (1)	PL308825A1 (ja)
RO (1)	RO113642B1 (ja)
SK (1)	SK72195A3 (ja)
TN (1)	TNSN95061A1 (ja)
ZA (1)	ZA954400B (ja)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9312853D0 (en)	1993-06-22	1993-08-04	Euro Celtique Sa	Chemical compounds
US5591776A (en)	1994-06-24	1997-01-07	Euro-Celtique, S.A.	Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en)	1994-06-24	1999-07-13	Euro-Celtique, S.A.	Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6166041A (en)	1995-10-11	2000-12-26	Euro-Celtique, S.A.	2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en)	1996-04-10	2000-06-13	Euro-Celtique S.A.	6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en)	1996-07-12	1996-09-04	Bayer Ag	3-ureido-pyridofurans and -pyridothiophenes
US5908859A (en) *	1997-08-11	1999-06-01	Eli Lilly And Company	Benzothiophenes for inhibiting hyperlipidemia
CA2715683A1 (en)	1999-08-21	2001-03-01	Nycomed Gmbh	Synergistic combination
KR100965021B1 (ko) *	2002-02-22	2010-06-21	바이엘 파마슈티칼스 코포레이션	과다증식성 질환 치료에 유용한 벤조푸란 및 벤조티오펜유도체
US7144885B2 (en)	2002-02-22	2006-12-05	Bayer Pharmaceuticals Corporation	Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
US7153824B2 (en)	2003-04-01	2006-12-26	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
EP1644360A1 (en) *	2003-06-05	2006-04-12	Warner-Lambert Company LLC	3-substituted indoles and derivatives thereof as therapeutic agents
CA2527934A1 (en) *	2003-06-05	2004-12-16	Warner-Lambert Company Llc	Tetrazol benzofurancarboxamides with p13k activity as therapeutic agents
US20040259926A1 (en) *	2003-06-05	2004-12-23	Bruendl Michelle M.	3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
WO2004108716A1 (en) *	2003-06-05	2004-12-16	Warner-Lambert Company Llc	3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
CA2527573A1 (en) *	2003-06-05	2004-12-16	Warner-Lambert Company Llc	Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
BRPI0410940A (pt) *	2003-06-05	2006-08-29	Warner Lambert Co	benzo[b]tiofenos substituìdos com cicloalquilsulfanila como agentes terapêuticos
CN1845914A (zh) *	2003-09-02	2006-10-11	默克公司	用于治疗眼压过高的眼用组合物
CA2666469A1 (en) *	2006-09-01	2008-03-06	Bayer Healthcare Ag	Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es)	2007-06-04	2018-03-21	Synergy Pharmaceuticals Inc	Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
ES2522968T3 (es)	2008-06-04	2014-11-19	Synergy Pharmaceuticals Inc.	Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en)	2008-07-16	2015-02-19	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
CN102282155B (zh)	2008-12-02	2017-06-09	日本波涛生命科学公司	磷原子修饰的核酸的合成方法
RU2612521C2 (ru)	2009-07-06	2017-03-09	Онтории, Инк.	Новые пролекарства нуклеиновых кислот и способы их применения
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
JP5868324B2 (ja)	2010-09-24	2016-02-24	株式会社Wave Life Sciences Japan	不斉補助基
DK2681236T3 (en)	2011-03-01	2018-04-16	Synergy Pharmaceuticals Inc	PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
CN103796657B (zh)	2011-07-19	2017-07-11	波涛生命科学有限公司	合成官能化核酸的方法
PL2872485T3 (pl)	2012-07-13	2021-05-31	Wave Life Sciences Ltd.	Asymetryczna grupa pomocnicza
US8883857B2 (en)	2012-12-07	2014-11-11	Baylor College Of Medicine	Small molecule xanthine oxidase inhibitors and methods of use
WO2014131024A2 (en)	2013-02-25	2014-08-28	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235215A1 (en)	2013-03-15	2015-10-01	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014235209B2 (en)	2013-03-15	2018-06-14	Bausch Health Ireland Limited	Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt)	2013-06-05	2017-08-29	Synergy Pharmaceuticals Inc	Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en)	2013-08-09	2019-08-29	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
BR112016016400A2 (pt)	2014-01-16	2017-10-03	Wave Life Sciences Ltd	Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
EP4706758A3 (en)	2019-05-21	2026-05-06	Ardelyx, Inc.	Methods for inhibiting phosphate transport

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0146243A1 (en)	1983-10-31	1985-06-26	Merck Frosst Canada Inc.	Lipoxygenase inhibitors
US5120742A (en) *	1984-02-27	1992-06-09	Merck & Co., Inc.	17 β-acyl-4-aza-5 α-androst-1-ene-3-ones as 5 α-reductase inhibitors
GB9200623D0 (en) *	1992-01-13	1992-03-11	Bayer Ag	Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) *	1993-05-06	1993-06-16	Bayer Ag	Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives

1995
- 1995-05-15 HR HR9410863.6A patent/HRP950288A2/xx not_active Application Discontinuation
- 1995-05-18 DE DE69504753T patent/DE69504753T2/de not_active Expired - Fee Related
- 1995-05-18 DK DK95107604T patent/DK0685474T3/da active
- 1995-05-18 AT AT95107604T patent/ATE171172T1/de not_active IP Right Cessation
- 1995-05-18 ES ES95107604T patent/ES2124461T3/es not_active Expired - Lifetime
- 1995-05-18 EP EP95107604A patent/EP0685474B1/en not_active Expired - Lifetime
- 1995-05-23 US US08/448,212 patent/US5565488A/en not_active Expired - Fee Related
- 1995-05-25 AU AU20286/95A patent/AU695464B2/en not_active Ceased
- 1995-05-26 CA CA002150301A patent/CA2150301A1/en not_active Abandoned
- 1995-05-26 NZ NZ272217A patent/NZ272217A/en unknown
- 1995-05-29 FI FI952612A patent/FI952612L/fi unknown
- 1995-05-29 IL IL11389495A patent/IL113894A/xx active IP Right Grant
- 1995-05-29 PL PL95308825A patent/PL308825A1/xx unknown
- 1995-05-29 JP JP7153826A patent/JPH083154A/ja active Pending
- 1995-05-29 TN TNTNSN95061A patent/TNSN95061A1/fr unknown
- 1995-05-29 MA MA23904A patent/MA23603A1/fr unknown
- 1995-05-30 KR KR1019950013805A patent/KR950032163A/ko not_active Withdrawn
- 1995-05-30 MY MYPI95001417A patent/MY130580A/en unknown
- 1995-05-30 HU HU9501569A patent/HUT71597A/hu unknown
- 1995-05-30 CN CN95106609A patent/CN1119187A/zh active Pending
- 1995-05-30 ZA ZA954400A patent/ZA954400B/xx unknown
- 1995-05-30 NO NO952129A patent/NO952129L/no unknown
- 1995-05-30 CO CO95023181A patent/CO4600675A1/es unknown
- 1995-05-30 SK SK721-95A patent/SK72195A3/sk unknown
- 1995-05-30 EE EE9500034A patent/EE9500034A/xx unknown
- 1995-05-30 BG BG99680A patent/BG99680A/xx unknown
- 1995-05-30 RO RO95-01066A patent/RO113642B1/ro unknown
- 1995-05-31 CZ CZ951408A patent/CZ140895A3/cs unknown
- 1995-05-31 LV LVP-95-146A patent/LV11467B/en unknown

Also Published As

Publication number	Publication date
IL113894A0 (en)	1995-08-31
CZ140895A3 (en)	1995-12-13
TNSN95061A1 (fr)	1996-02-06
IL113894A (en)	1999-06-20
CO4600675A1 (es)	1998-05-08
FI952612A0 (fi)	1995-05-29
KR950032163A (ko)	1995-12-20
ATE171172T1 (de)	1998-10-15
FI952612A7 (fi)	1995-12-01
JPH083154A (ja)	1996-01-09
FI952612L (fi)	1995-12-01
HRP950288A2 (en)	1997-08-31
AU2028695A (en)	1995-12-07
EE9500034A (et)	1995-12-15
ES2124461T3 (es)	1999-02-01
SK72195A3 (en)	1995-12-06
LV11467B (en)	1996-12-20
CN1119187A (zh)	1996-03-27
CA2150301A1 (en)	1995-12-01
DE69504753D1 (de)	1998-10-22
MY130580A (en)	2007-06-29
AU695464B2 (en)	1998-08-13
NO952129L (no)	1995-12-01
RO113642B1 (ro)	1998-09-30
DK0685474T3 (da)	1999-06-14
NO952129D0 (no)	1995-05-30
EP0685474A1 (en)	1995-12-06
NZ272217A (en)	1997-02-24
PL308825A1 (en)	1995-12-11
MA23603A1 (fr)	1996-04-01
ZA954400B (en)	1996-01-24
US5565488A (en)	1996-10-15
HUT71597A (en)	1996-01-29
EP0685474B1 (en)	1998-09-16
LV11467A (lv)	1996-08-20
DE69504753T2 (de)	1999-02-04
HU9501569D0 (en)	1995-07-28

Publication	Publication Date	Title
BG99680A (en)	1996-01-31	Derivatives of oxalylaminobenzofuran and oxalylaminobenzothienyl
DE3868076D1 (de)	1992-03-12	Heterocyclische derivate, verfahren zu ihrer herstellung und diese derivate als aktive bestandteile enthaltende fungizide.
FI925913L (fi)	1994-06-30	Menetelmä -olefiinien polymeroimiseksi sekä esipolymeroitu katalyyttikompositio ja menetelmä tämän valmistamiseksi
ATE17349T1 (de)	1986-01-15	Neue trisubstituierte imidazolderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
DE3677478D1 (de)	1991-03-14	N-benzoylharnstoffverbindungen, diese enthaltende antitumorzusammensetzungen und verfahren zu deren herstellung.
DE69019180D1 (de)	1995-06-14	Organopolysiloxan-Polyharnstoff Blockcopolymer und Methode zu seiner Herstellung.
DE3582110D1 (de)	1991-04-18	Verdickungsmittel, verfahren zur herstellung und ihre verwendung.
ATE3859T1 (de)	1983-07-15	Pyridoxin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
MY117381A (en)	2004-06-30	Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
ATE9160T1 (de)	1984-09-15	Thienopyridinonderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
EP0136569A3 (en)	1987-01-07	Isoflavone derivatives, their production and use
MXPA03001536A (es)	2004-05-04	(aminoalcoxibenzoil) benzofuranos o benzotiofenos, metodo para preparar los mismo y composiciones que los contienen.
FI971264L (fi)	1997-03-26	Menetelmä 2,6-di-isopropyylifenolin puhdistamiseksi
DE3675197D1 (de)	1990-11-29	Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel.
ZA979059B (en)	1998-05-07	10, 13, 15-Trioxatricyclo [9.2.1.1.<9.6>]-pentadecanone derivatives, method for the production thereof and medicaments containing these compounds.
EP0612529A3 (en)	1997-01-15	Therapeutic agent for NIDDM.
MY125674A (en)	2006-08-30	Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
GB2287953B (en)	1996-06-12	High stability, organic tanning processes
EP0668264A3 (de)	1997-05-02	Schwefelorganische Goldverbindungen, Verfahren zu ihrer Herstellung und Verwendung derselben.
IL113357A (en)	2000-10-31	Process for preparing alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid O, S-esters
MX9603516A (es)	1997-03-29	Derivados de oxima y su uso como pesticidas.
ITMI911877A1 (it)	1993-01-08	Enzimi fibrinolitici ammidati e loro precursori, e processi per la loro preparazione.
ES2138215T3 (es)	2000-01-01	Metodo para eliminar un color no deseado de acido clorhidrico.
ZA82347B (en)	1983-08-31	New organic compounds,processes for their production and their use
DE3382664D1 (de)	1993-04-22	Neue chlormethylchinolin-derivate, verfahren zu ihrer herstellung und ihre verwendung.